ZIDAS Site Demand Genethera’s exclusivity agreement with Cushman & Wakefield to identify land sites and warehouse buildings in Denver for the ZIDAS zoonotic disease surveillance network signals demand for lab-ready facilities and turn-key site development. Use this momentum to engage real estate developers, lab builders, and campus operators with site selection, lab fit-out, cleanroom design, permitting, and equipment installation services.

Lab Automation The company’s work on advanced integrated laboratory robotic platforms points to opportunities for robotics vendors, systems integrators, and LIMS partners to supply equipment, integration, validation, and ongoing maintenance that fit Genethera’s rapid-detection objectives.

Small Biotech Needs With minimal revenue and a small-to-mid size team, Genethera is likely to outsource specialized capabilities like data analytics, cloud hosting, cybersecurity, GMP-adjacent compliance, and grant support. Position modular, scalable services or pilot projects to align with tight budgets and growth plans.

Tech Modernization The current tech stack (jQuery, PHP, GoDaddy, Apache) suggests a gap in modern software infrastructure. Promote modernization services including secure hosting, cloud migration, API integration, and managed application development tailored to biotech workflows.

Strategic Partnerships Genethera’s collaboration with Cushman & Wakefield indicates openness to ecosystem partnerships. Explore co-sell or referral arrangements with CROs, lab equipment suppliers, facility services firms, and real estate developers to accelerate lab deployment and surveillance network scale.